- Home
- SIEB vs TLSA Comparison
SIEB vs TLSA Comparison
Compare SIEB & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- TLSA
- Stock Information
- Founded
- SIEB 1886
- TLSA 2013
- Country
- SIEB United States
- TLSA United Kingdom
- Employees
- SIEB N/A
- TLSA N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SIEB Finance
- TLSA Health Care
- Exchange
- SIEB Nasdaq
- TLSA Nasdaq
- Market Cap
- SIEB 94.9M
- TLSA 87.8M
- IPO Year
- SIEB N/A
- TLSA 2000
- Fundamental
- Price
- SIEB $3.01
- TLSA $0.74
- Analyst Decision
- SIEB
- TLSA
- Analyst Count
- SIEB 0
- TLSA 0
- Target Price
- SIEB N/A
- TLSA N/A
- AVG Volume (30 Days)
- SIEB 23.7K
- TLSA 442.0K
- Earning Date
- SIEB 11-12-2024
- TLSA 01-28-2025
- Dividend Yield
- SIEB N/A
- TLSA N/A
- EPS Growth
- SIEB 61.43
- TLSA N/A
- EPS
- SIEB 0.27
- TLSA N/A
- Revenue
- SIEB $83,357,000.00
- TLSA N/A
- Revenue This Year
- SIEB N/A
- TLSA N/A
- Revenue Next Year
- SIEB N/A
- TLSA N/A
- P/E Ratio
- SIEB $11.18
- TLSA N/A
- Revenue Growth
- SIEB 27.81
- TLSA N/A
- 52 Week Low
- SIEB $1.41
- TLSA $0.41
- 52 Week High
- SIEB $3.34
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- SIEB 50.35
- TLSA 44.91
- Support Level
- SIEB $2.91
- TLSA $0.68
- Resistance Level
- SIEB $3.34
- TLSA $0.80
- Average True Range (ATR)
- SIEB 0.17
- TLSA 0.08
- MACD
- SIEB -0.03
- TLSA 0.01
- Stochastic Oscillator
- SIEB 43.10
- TLSA 34.34
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.